Want to join the conversation?
$PFE's Global Innovative Pharmaceuticals segment revenues increased 10% in 3Q15 operationally, primarily due to the strong operational performance of Eliquis globally, Lyrica primarily in US, Enbrel in most international markets as well as Xeljanz and Viagra partially offset by generic competition for Rapamune in the US.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!